L. Patmore et al., Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin oncardiac action potential duration, EUR J PHARM, 406(3), 2000, pp. 449-452
Fluoroquinolone antibiotics have been associated with QT prolongation follo
wing administration to humans. This study compares the effects of four fluo
roquinolones, sparfloxacin, grepafloxacin, moxifloxacin and ciprofloxacin e
naction potential duration recorded from canine isolated cardiac Purkinje f
ibres. Left and right ventricular Purkinje fibres were isolated from canine
hearts and continuously superfused with physiological salt solution. Actio
n potential duration at 90% repolarization was recorded via intracellular m
icroelectrodes. Sparfloxacin, grepafloxacin, moxifloxacin and ciprofloxacin
prolonged action potential duration in a concentration dependent manner. M
ean concentrations causing a 15% prolongation of action potential duration
recorded at a stimulation frequency of 1 Hz were: sparfloxacin 4.2 +/- 0.7
mug/ml; grepafloxacin 9.3 +/- 0.9 mug/ml; moxifloxacin 9.9 +/- 1.6 mug/ml a
nd ciprofloxacin 72.8 +/- 26.4 mug/ml. Prolongation was inverse frequency d
ependent with larger increases in action potential duration occurring when
the stimulation frequency was reduced to 0.5 Hz. These results indicate tha
t effects on action potential duration vary within this class of compound.
Rank order of potency was sparfloxacin > grepafloxacin = moxifloxacin > cip
rofloxacin. (C) 2000 Elsevier Science B.V. All rights reserved.